HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fosfomycin: efficacy against infections caused by multidrug-resistant bacteria.

AbstractOBJECTIVE:
To analyze the indications for and the efficacy of parenteral fosfomycin, especially against multidrug-resistant (MDR) and pan-resistant bacterial infections.
PATIENTS AND METHODS:
During a unique crisis in fosfomycin production, the supply of this antibiotic had to be carefully monitored in France over a 10-week period. One hundred and sixteen assessable patients were included in a prospective cohort study.
RESULTS:
The main indications for use were osteoarthritis, lung infection, urinary tract infection, and bacteraemia. The 2 bacteria most frequently involved were Pseudomonas aeruginosa and methicillin-resistant Staphylococcus. MDR bacteria were seen in 71.5% (83/116) of cases, especially MDR P. aeruginosa (n = 28). Critical situations were common, with 44.0% (51/116) of hospitalizations occurring in an intensive care unit and 22.4% (26/116) of patients with septic shock. The overall outcome was favourable in 76.8% of cases (76/99 assessable patients).
CONCLUSION:
This study provided a unique opportunity to describe the use of fosfomycin and assess its efficacy, especially against MDR bacterial infections, even in critical situations.
AuthorsAurélien Dinh, Jérôme Salomon, Jean Pierre Bru, Louis Bernard
JournalScandinavian journal of infectious diseases (Scand J Infect Dis) Vol. 44 Issue 3 Pg. 182-9 (Mar 2012) ISSN: 1651-1980 [Electronic] England
PMID22176655 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Fosfomycin
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents (administration & dosage, pharmacology)
  • Bacteria (drug effects, isolation & purification)
  • Bacterial Infections (drug therapy, microbiology)
  • Child
  • Child, Preschool
  • Cohort Studies
  • Drug Resistance, Multiple, Bacterial
  • Female
  • Fosfomycin (administration & dosage, pharmacology)
  • France
  • Humans
  • Infant
  • Male
  • Middle Aged
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: